Wassim Kassouf, MD
Primary Axis:
Cancer
Email:
Email contact form Research Focus:
Research focuses on biology and therapy for bladder cancer with a primary emphasis on molecular therapeutics targeting signaling pathways in urothelial carcinomaOutcome assessment, bladder cancer, targeted therapy, signaling, angiogenesis
Keywords:
Outcome assessment, bladder cancer, targeted therapy, signaling, angiogenesis
Location:
Montreal General Hospital Publications:
Kassouf W, Black PC, Tuziak T, Bondaruk J, Lee S, Brown GA, Adam L, Wei C, Baggerly K, Bar-Eli M, McConkey D, Czerniak B, Dinney CP. Distinctive expression pattern of ErbB family receptors signifies an aggressive variant of bladder cancer. J Urol. 179: 353-35; 2008.
Kassouf W, Chintharlapalli S, Abdelrahim M, Nelkin G, Safe S, and Kamat AM. Inhibition of Bladder Tumor Growth by 1,1-Bis(3'-indolyl)-1-(p-substitutedphenyl)methanes: A New Class of Peroxisome Proliferator-activated Receptor Agonists. Cancer Research 66: 412-418; 2006
Kassouf W, Dinney C, Brown G, McConkey DJ, Diehl AJ, Bar-Eli M, and Adam L. Glycogen Synthase Kinase-3 Regulation As A Marker of Sensitivity to Gefitinib-Induced Cytostatic Effect in Bladder Cancer Cells. Cancer Research 65: 10524-10535; 2005
